한글목차

치과 연부조직 재생 시장 규모는 예측 기간 중 7.8%의 CAGR로 확대하며, 2024년 3억 7,000만 달러에서 2029년에는 5억 4,000만 달러에 달할 것으로 예측됩니다. 치과 연부조직 재생 시장은 치주질환의 유병률 증가, 구강 건강에 대한 인식 증가, 심미치과 동향 증가 등 여러 요인으로 인해 강력한 성장세를 보이고 있습니다. 또한 저개발 지역의 의료 인프라 개발 구상은 더 많은 치과 치료 및 관련 제품에 대한 수요를 요구하고 있습니다. 또한 재생 생체 재료의 발전도 시장 성장에 큰 역할을 하고 있습니다.

제품 유형별로는 콜라겐 기반 멤브레인 부문이 몇 가지 요인으로 인해 치과용 연조직 재생 시장을 주도할 것으로 예상됩니다. 콜라겐 기반 막은 치주 결손 및 임플란트 결손의 치유를 지원하고 조직 성장을 유도하는 장벽 역할을 합니다. 또한 이 막은 주변 조직과 통합할 수 있는 능력을 가지고 있으며, 새로운 결합조직의 성장을 지원합니다. 또한 재생 생체 재료의 기술 혁신은 이 시장의 성장을 더욱 촉진하고 있습니다.

용도별로는 임플란트 분야가 고령화 인구 증가, 구강 건강에 대한 인식 증가, 심미 치과에 대한 수요 증가로 인해 치과 연조직 재생 시장에서 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 또한 임플란트 주변 연조직의 치유를 촉진하기 위해 콜라겐 막, 연조직 이식편, 첨단 생체활성 물질과 같은 제품이 점점 더 많이 사용되고 있습니다. 또한 연조직 재생 솔루션의 기술 혁신과 치과 미학에 대한 인식이 높아지면서 치과 연조직 재생 시장의 성장을 더욱 촉진하고 있습니다.

세계의 치과 연부조직 재생 시장에 대해 조사했으며, 제품 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 업계 동향
• 밸류체인 분석
• 기술 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 규제 상황 분석
• 특허 분석
• 무역 분석
• 가격 분석
• 2024-2025년의 주요 컨퍼런스와 이벤트
• 미충족 요구/최종사용자 기대
• 인접 시장 분석
• 에코시스템 분석
• 사례 연구 분석
• 공급망 분석
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 투자와 자금조달 시나리오
• 상환 시나리오 분석
• AI/생성형 AI가 치과 연부조직 재생 시장에 미치는 영향
• 잇몸 질환의 유병률, 주요 지역별, 2023년
• 2023년 주요 지역별 수술 총수

제6장 치과 연부조직 재생 시장(제품 유형별)

• 서론
  • 콜라겐 기반 멤브레인
  • 자가 이식
  • 합성 바이오소재
  • 기타

제7장 치과 연부조직 재생 시장(용도별)

• 서론
  • 임플란트학
  • 치주질환학
  • 기타

제8장 치과 연부조직 재생 시장(최종사용자별)

• 서론
• 치과의원
• DSO·독립 클리닉
• 학술연구기관

제9장 치과 연부조직 재생 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타
• 중동 및 아프리카
  • 시장의 성장을 지원하는 인프라 개발에 대한 정부 구상
  • 중동 및 아프리카의 거시경제 전망
• GCC 국가
  • 가처분소득의 증가가 시장의 성장을 촉진
  • GCC 국가의 거시경제 전망

제10장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/강점
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 참여 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 브랜드/제품 비교
• 주요 기업의 연구개발비
• 기업 평가와 재무 지표
• 경쟁 시나리오

제11장 기업 개요

• 주요 참여 기업
  • GEISTLICH PHARMA AG
  • INSTITUT STRAUMANN AG
  • HENRY SCHEIN, INC.
  • ENVISTA
  • ZIMVIE INC.
  • DENTSPLY SIRONA INC.
  • ABBVIE INC.
  • ADVANCED MEDICAL SOLUTIONS GROUP PLC
  • TISSUE REGENIX
  • SEPTODONT HOLDING
  • MEDICAL CONSULT IMPLANTS GMBH
  • MECCELLIS BIOTECH
  • REGEDENT AG
  • REGENITY
  • AD SURGICAL
• 기타 기업
  • LIFENET HEALTH
  • B. & B. DENTAL S.R.L.
  • ALPHA-BIO TEC. LTD.
  • LASAK S.R.O.
  • KEYSTONE DENTAL GROUP
  • NEOSS AG
  • BEGO GMBH & CO. KG
  • BIOTECH DENTAL
  • SAMYANG HOLDINGS CORPORATION
  • RTI SURGICAL

제12장 부록

영문목차

The dental soft-tissue regeneration market is projected to reach USD 0.54 billion by 2029 from USD 0.37 billion in 2024, at a CAGR of 7.8% during the forecast period. The dental soft-tissue regeneration market has had strong growth due to a number of factors such as the rising incidences of periodontal diseases, increasing awareness of oral health, and growing trend of cosmetic dentistry. Moreover, the initiatives to develop healthcare infrastructure in underdeveloped regions demand more dental treatments and related products. Additionally, the advancements in regenerative biomaterials has also played a major role in the market's growth.

"By product type, collagen-based segment is expected to have the largest market share in the dental soft-tissue regeneration market."

Based on the product type, the collagen-based membrane segment is expected to dominate the the dental soft-tissue regeneration market due to several factors. Collagen-based membranes acts as barriers to guide tissue growth, where they support the healing of periodontal defects and implant-based defects. Moreover, these membrnes have the ability to integrate with surrounding tissues and supports the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials further support the growth of this market.

"By application, implantology segment is expected to have the largest market share in the dental soft-tissue regeneration market."

Based on application, the implantology segment is expected to hold the largest market share in the dental soft-tissue regeneration market due to the growing aging population, increasing awareness of oral health and increasing demand for cosmetic dentistry. Moreover, to promote healing in peri-implant soft tissues, products like collagen membranes, soft tissue grafts, and advanced bioactive materials are increasingly used. Additionally, innovations in soft tissue regenerative solutions, and increasing awareness of dental aesthetics further support the growth of dental soft-tissue regeneration market.

"By region, North American region is expected to have the largest market share in the dental soft-tissue regeneration market."

North America to register for the highest share of the dental soft-tissue regeneration market during the forecast period due to several factors. The presence of advanced healthcare infrastructure, and high health expenditure rates drive the demand for advanced dental care treatments in this region. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in North America. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting advance dental care treatments. Additonaly, the ongoing research and development in dental technologies and biomaterials, also support this expansion in this region.

A breakdown of the primary participants (supply-side) for the dental soft-tissue regeneration market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-45%, Director Level-35%, and Others-20%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), Dentsply Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), Bego GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).

Research Coverage:

The report analyzes the dental soft-tissue regeneration market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental soft-tissue regeneration market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services, and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries) and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
• Market Penetration: It includes extensive information on products offered by the major players in the global the dental soft-tissue regeneration market. The report includes various segments in product type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the dental soft-tissue regeneration market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary research
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Objectives of primary research
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.3 TOP-DOWN APPROACH: SUPPLY-SIDE ANALYSIS
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW
• 4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE AND COUNTRY (2023)
• 4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX
• 4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
• 4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of periodontal diseases
    • 5.2.1.2 Growing demand for cosmetic dentistry
    • 5.2.1.3 Rising popularity of biodegradable biomaterials
    • 5.2.1.4 Advancements in regenerative technologies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services
    • 5.2.2.2 Dearth of trained dental practitioners
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Introduction of dental service organizations and consolidation of dental practices
    • 5.2.3.2 Growth opportunities in emerging economies
    • 5.2.3.3 Increasing popularity of dental tourism in emerging countries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Pricing pressure and increased market competition
    • 5.2.4.2 Stringent regulatory environment
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY
  • 5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 TECHNOLOGY ANALYSIS
  • 5.5.1 KEY TECHNOLOGIES
    • 5.5.1.1 3D bioprinting
  • 5.5.2 COMPLEMENTARY TECHNOLOGIES
    • 5.5.2.1 Laser-assisted technology
  • 5.5.3 ADJACENT TECHNOLOGIES
    • 5.5.3.1 Advanced biomaterials
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 THREAT OF SUBSTITUTES
  • 5.6.3 BARGAINING POWER OF SUPPLIERS
  • 5.6.4 BARGAINING POWER OF BUYERS
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.7.2 KEY BUYING CRITERIA
• 5.8 REGULATORY LANDSCAPE ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY FRAMEWORK
    • 5.8.2.1 North America
      • 5.8.2.1.1 US
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
      • 5.8.2.3.1 India
      • 5.8.2.3.2 China
      • 5.8.2.3.3 Japan
• 5.9 PATENT ANALYSIS
  • 5.9.1 KEY PATENTS GRANTED
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 300640
  • 5.10.2 EXPORT DATA FOR HS CODE 300640
• 5.11 PRICING ANALYSIS
  • 5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER
  • 5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 UNMET NEEDS/END-USER EXPECTATIONS
• 5.14 ADJACENT MARKET ANALYSIS
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 CASE STUDY ANALYSIS
• 5.17 SUPPLY CHAIN ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.19 INVESTMENT & FUNDING SCENARIO
• 5.20 REIMBURSEMENT SCENARIO ANALYSIS
• 5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET
• 5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2023
• 5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2023

6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE

• 6.1 INTRODUCTION
  • 6.1.1 COLLAGEN-BASED MEMBRANES
    • 6.1.1.1 Potential to enhance dental tissue regeneration to drive market
  • 6.1.2 AUTOGRAFTS
    • 6.1.2.1 High compatibility and reduced infection risks to drive market
  • 6.1.3 SYNTHETIC BIOMATERIALS
    • 6.1.3.1 Technological advancements in biomaterials to fuel market growth
  • 6.1.4 OTHER PRODUCTS

7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • 7.1.1 IMPLANTOLOGY
    • 7.1.1.1 Growing need for implant-supported soft-tissue regeneration to drive market
  • 7.1.2 PERIODONTOLOGY
    • 7.1.2.1 Increasing prevalence of periodontal diseases to favor market growth
  • 7.1.3 OTHER APPLICATIONS

8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 DENTAL HOSPITALS
  • 8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET
• 8.3 DSOS & INDEPENDENT CLINICS
  • 8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND
• 8.4 ACADEMIC & RESEARCH INSTITUTES
  • 8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH

9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American dental soft-tissue regeneration market
  • 9.2.3 CANADA
    • 9.2.3.1 Stringent regulatory compliance to support market growth in Canada
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to dominate dental soft-tissue regeneration market in Europe
  • 9.3.3 UK
    • 9.3.3.1 Rising number of geriatric patients to drive market
  • 9.3.4 FRANCE
    • 9.3.4.1 Well-established healthcare system to drive market
  • 9.3.5 SPAIN
    • 9.3.5.1 Government initiatives for providing dental coverage to support market growth
  • 9.3.6 ITALY
    • 9.3.6.1 Growing penetration of dental products to drive market growth
  • 9.3.7 REST OF EUROPE (ROE)
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Rising geriatric population to support market growth
  • 9.4.3 CHINA
    • 9.4.3.1 Growing geriatric population and increasing per capita income to support market growth
  • 9.4.4 INDIA
    • 9.4.4.1 Growing dental care sector to fuel market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Growing healthcare expenditure to aid market growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Well-developed healthcare sector to drive market
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Brazil to hold largest share in Latin American market
  • 9.5.3 MEXICO
    • 9.5.3.1 Increasing healthcare infrastructure to propel market growth
  • 9.5.4 ARGENTINA
    • 9.5.4.1 Advancements in dental technology to spur growth
  • 9.5.5 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Product footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 BRAND/PRODUCT COMPARISON
• 10.8 R&D EXPENDITURE OF KEY PLAYERS
• 10.9 COMPANY VALUATION & FINANCIAL METRICS
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES
  • 10.10.2 DEALS
  • 10.10.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 GEISTLICH PHARMA AG
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 INSTITUT STRAUMANN AG
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 MnM view
      • 11.1.2.3.1 Right to win
      • 11.1.2.3.2 Strategic choices
      • 11.1.2.3.3 Weaknesses & competitive threats
  • 11.1.3 HENRY SCHEIN, INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 ENVISTA
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Deals
  • 11.1.5 ZIMVIE INC.
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 DENTSPLY SIRONA INC.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
      • 11.1.6.3.2 Deals
    • 11.1.6.4 MnM view
      • 11.1.6.4.1 Right to win
      • 11.1.6.4.2 Strategic choices
      • 11.1.6.4.3 Weaknesses & competitive threats
  • 11.1.7 ABBVIE INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Expansions
  • 11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
  • 11.1.9 TISSUE REGENIX
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 SEPTODONT HOLDING
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
  • 11.1.11 MEDICAL CONSULT IMPLANTS GMBH
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 MECCELLIS BIOTECH
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 REGEDENT AG
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 REGENITY
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Deals
  • 11.1.15 AD SURGICAL
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 LIFENET HEALTH
  • 11.2.2 B. & B. DENTAL S.R.L.
  • 11.2.3 ALPHA-BIO TEC. LTD.
  • 11.2.4 LASAK S.R.O.
  • 11.2.5 KEYSTONE DENTAL GROUP
  • 11.2.6 NEOSS AG
  • 11.2.7 BEGO GMBH & CO. KG
  • 11.2.8 BIOTECH DENTAL
  • 11.2.9 SAMYANG HOLDINGS CORPORATION
  • 11.2.10 RTI SURGICAL

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS